Cambridge NeuroWorks’ Post

Isaac Newton once said that scientific progress is made by standing on the shoulders of giants. At The Wistar Institute, our renowned education & training programs prepare the next generation of scientists through unparalleled exposure to giants in the field of biomedical research. Wistar’s collaborations with universities like University of Pennsylvania, Philadelphia College of Osteopathic Medicine, and University of Bologna (Alma Mater Studiorum – Università di Bologna) allow doctoral students to pursue their research right here at Wistar, where leading experts in cancer research and immunotherapy train, guide, and mentor students on their research-career journeys. Interested in pursuing Ph.D. research at Wistar through one of these programs? Learn more: https://lnkd.in/ezYwPMmX #nationalmentoringmonth #mentoringmonth #mentorship #research

UCLA's move to create a cutting-edge research park signifies a leap towards groundbreaking discoveries in quantum science and immunology. However, the proposed reinterpretation of the Bayh-Dole Act by the Biden administration could dampen the spirit of university-based R&D and the journey of discoveries from lab to market. This act has historically facilitated vital partnerships, fueling the U.S. economy and job market. Upholding these innovation channels is essential https://lnkd.in/etv3gH8Z

After a Master is always difficult to decide whether is better academia or industry...ultimately is based on the mentor that you will have in the new position. Before entering in Industry I did a PhD which definitely helped me be who I am today ! For the people that want to make an impact in science and want to have a wonderful supervisor...i would highly reccommend applying to this position! #phd #science #development

Bridging Academia and Industry for Groundbreaking Research!!! Academia and industry are two prominent research wings, and quality studies often thrive through collaboration between both sectors. I recently had the incredible experience of partnering with the Parse Biosciences team including Graham Bloom, and learning about their advanced single nuclei RNA sequencing library assay from the exceptional field application scientist, Dr. John D. Thompson, PhD at Stanford University School of Medicine. The synergy between academia and industry in such collaborations truly enhances the quality of studies and drives impactful research outcomes. Looking ahead, I am eager to establish more partnerships of Stanford University's neuromuscular team with thriving industries to further our understanding of various neuromuscular disease development and treatment. Together, we can achieve remarkable progress in the field of biomedical research. 🌸 #Research #Collaboration #Academia #Industry #NeuromuscularDisease #ParseBiosciences #Innovation #Science #Marwazafarullah

Last week, I participated in a four-member panel to evaluate pitches from the second cohort of the University of Massachusetts Lowell Innovative Fellows Training (LIFT) program. The LIFT program trains doctoral candidates and postdocs in the sciences on entrepreneurship and coaches them on how to take novel ideas related to aging from the bench to market. There was a mini “Shark Tank” vibe to this event where nine Fellows presented their ideas, market analysis, business plan, and needs to our expert panel for feedback. Our panel included neuroscientists, data scientists, an investor, and me! Pison is developing cutting-edge wearables and applications for tracking brain health and fatigue, which are both huge concerns for the aging population, so the LIFT focus area is very relevant. We heard about projects for businesses that would provide improved ·       Circadian rhythm monitoring in Alzheimer’s Disease, ·       “Matchmaking” for researchers and contract research organizations, ·       Treatment for mitochondrial DNA damage for macular degeneration, ·       Assessments of the microbiome through organoids, ·       Access to fruit fly stem cells to answer research questions, ·       Understanding of the roles of non-coding RNAs, oligodendrocyte precursor cells, and G-quadruplexes (three separate pitches). The LIFT program was established to help scientists prepare for a career in business, as not everyone will enter careers in academia. I was impressed by how far these Fellows have come in developing a business plan and strategy in just three months!

The University of Wisconsin-Madison has moved up two places to sixth out of 920 public and private universities in the United States in #university #research expenditures, according to the National Science Foundation (NSF) annual rankings. For the first time, the university has topped $1.7 billion in research expenditures, according to the NSF Higher Education Research and Development (HERD), released today, Nov. 25, 2024. “UW–Madison’s research success, as evidenced by the HERD Survey, includes collaborative efforts to connect faculty to more #funding opportunities,” says Vice Chancellor for Research Dorota Grejner-Brzezinska. “We are increasing campus engagement with our partners and fostering an entrepreneurial environment that supports our commitment to advancing scientific discovery and facilitates researchers moving their innovations from lab to marketplace. We are seeing increased support for research into #Alzheimers, childhood #asthma, combating the fentanyl crisis, and traumatic brain injuries. We are combining #data-driven diagnostics and innovative technologies to develop highly targeted #cancer treatments with investments in areas such as #precisionmedicine.” Article: 'UW–Madison 6th in national research ranking, surpasses $1.7 billion in research expenditures' https://lnkd.in/g2tFHNUx via UW–Madison #education #leadership #health #innovation #clinicalresearch

✨ BNN spotlights Early Career Researchers ✨ Thomas Altendorfer-Kroath shares his research on #glioblastoma and the blood-brain barrier / blood-tumor barrier in the upcoming BNN QUARTERLY. He is a research scientist at JOANNEUM RESEARCH HEALTH - Institute for Biomedical Research and Technologies. #braincancer #cancerresearch

🎓 Today: Join us for as seminar on Reproducibility in Research! 🎓 Our research group is excited to welcome Professor Florian Naudet from the University of Rennes, University Institute of France (IUF) to lead a seminar on a topic at the center of scientific progress: reproducibility in research. 🔍 The reproducibility of scientific findings is essential for ensuring reliability and trust in research, yet challenges in achieving it have led to a discussion about a potential ‘reproducibility crisis’. Professor Naudet will break down this complex issue, addressing: ✔        Reproducibility of methods: Ensuring study procedures are detailed enough to be exactly repeatable. ✔       Reproducibility of results (replication): Achieving identical results with independent replication. ✔        Inferential reproducibility: Consistently drawing the same conclusions from re-analyses or new experiments. With examples from psychology, cancer biology, and clinical research, Professor Naudet will highlight key challenges in reproducing findings. He will also discuss possible solutions, including prospective registration, data sharing, and large-scale replication efforts.   🗓 Date: Today (Thursday 7 November) 🕒 Time: 15:00 CET 📍 Platform: Zoom (in English)   The seminar is open to anyone to attend, by using the following zoom link: https://lnkd.in/dvBGfp2J   #Research #Reproducibility #UCARE

Synchrony is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and venture partners from around the world with the mission to improve the health and quality of life of people with autism. Why submit an abstract to Synchrony? Present to a worldwide audience of top academic minds in scientific/medical specialities, to benefit individuals with autism, physicians, researchers and caregivers. ** Free registration for Synchrony 2025. Competitive pricing for students. ** Opportunity to win awards and prizes- First time Synchrony speakers are eligible for the 'BRAIN investigator award from the BRAIN Foundation. ** Present case study reports to be considered for special grants. ** Opportunity to learn and participate on-site in programs like the Mentor-Mentee program, for up and coming researchers with scientific leaders in the field. ** Networking opportunities with leading researchers/physicians in the field, at special outdoor social events ** Meet in-person with individuals/families/caregivers whose lives your work will impact ** Opportunities for the community to present to a greater audience, have their voice heard and be a part of the movement We invite you to submit an abstract for an oral presentation. Physicians, faculty, residents, post-doctoral scholars and early-career faculty are encouraged to avail of this exclusive opportunity. Submit your abstract here: https://lnkd.in/ediaKkE4 Please share widely with your colleagues and connections! Synchrony 2025 details and registrations: https://lnkd.in/edCF_G9u #autismspectrumdisorder #translationalresearch #researchers #neuroscience #brain

Following last week's announcement that our new Chief Scientific & Innovation Officer Louise Jopling will be leading, on behalf of the Campus, oversight of the fellowship programme of the collaboration between multiple Cambridge partners and the Advanced Research + Invention Agency (ARIA), we thought now might be an opportune time to revisit what this involves. A large team from across the Cambridge life sciences, technology and business worlds have come together as Activation Partners in ARIA’s Scalable Neural Interfaces opportunity space, which aims to super charge progress on a new generation of neuro-technologies designed to treat conditions such as depression, dementia, chronic pain, epilepsy and injuries to the nervous system. It consists of two programmes over the three-year collaboration period to fast-track radical new technologies to revolutionise brain health: 🌟 A fellowship programme which will see innovators from across the UK supported to translate their exciting ideas. Blue Sky Fellows will receive funding to rapidly test their idea in Cambridge, along with mentorship from our best medical, scientific and business experts. While those who have proof of concept validation for their neuro-technology and need support to turn it into a business can apply to be an Frontier Fellow and offered training in entrepreneurial skills. We will be sharing details of how to apply for the first tranche of Fellows in the coming weeks. 🌟 The ecosystem programme will create a vibrant, UK-wide neurotechnology community where leaders from business, science, engineering, academia and the NHS can meet, spark ideas and form collaborations. The other partners involved are – The Milner Therapeutics Institute, The Maxwell Centre, University of Cambridge, The Departments of Engineering and Psychiatry and Cambridge Neuroscience at the University of Cambridge, Cambridge University Health Partners, Cambridge Network, Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) and Vellos. Catch up here - https://ow.ly/Y8QT50U53L5